Thank You everyone, especiallly SPCEO1 !
I have been lurking on this board since 2010, posted several posts under another User ID (which I lost its password !). Anyhow, thanks for helping me keeping faith during rough time.
In your opinion, SPCEO1, what would you think if Thera would acquire a promising biotech/pharma in US with promising pipeline, huge NOLs, yet small market cap ? Would that acquisition achieve multiple objectives:
1/ Expand product portfolio.
2/ Offset future profits (NOL)
3/ Obtain NASDAQ listing and US market presence without having to pay huge costs.